Europlasma : CHO Morcenx: FAR protocol to resume in September

In accordance with the planning set out in the communication released on 27 July, CHO Power confirms resumption of the FAR (Final Acceptance with Reserves) protocol this month.
As a reminder, FAR requires successful execution of a series of tests. Amongst these, a major milestone has been achieved in June, since as part of a 15-day test, the CHO Morcenx gasification plant demonstrated its capacity to reach maximum performance.
The failure of an auxiliary equipment (high voltage transformer feeding the rectifier) forced CHO Power to suspend the FAR protocol temporarily. Root cause analysis has been completed with the support of the manufacturer, a solution has been identified and technically validated, it is currently being set up in the plant, to shortly allow resumption and finalization of the FAR protocol.
Jean-Eric Petit, CEO, declares: "The transformer incident, totally outside the control of CHO Power, illustrates the sometimes painful imponderables of innovation. I congratulate the CHO Power and CHOPEX teams, as well as our partners, for having so promptly identified and set up a solution allowing adherence to the FAR planning, and to the timing of deployment of future plants. This incident validates in any case the choices of design and equipment for these future plants, including CHO Tiper, ensuring the dependability of the process by prioritizing robustness and industrial redundancy."

The company reminds its shareholders that, in accordance with stock exchange regulations, it can not be individually answered the questions regarding inside information. The only official mean is the press release. Therefore the Company invites its shareholders to subscribe to the mailing list at the following address contactbourse@europlasma.com.

At the heart of environmental issues, EUROPLASMA designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint.

EUROPLASMA is listed on Alternext (FR0000044810-ALEUP). For more information: www.europlasam.com

Press and investor contacts

Tel: + 33 (0) 556 497 000 - contactbourse@europlasma.com

distributed by